Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 2Neoplasms 2Uterine Cervical Neoplasms 1Metastatic Solid Tumors 1Cholangiocarcinoma 1Camurati-Engelmann Syndrome 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Cisplatin 2vactosertib 1fludarabine 1enzalutamide 1bintrafusp alfa protein, human 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Paclitaxel 1LY3300054 1Gemcitabine 1Fenretinide 1Cyclophosphamide 1Carboplatin 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Camurati-Engelmann Syndrome × bintrafusp alfa protein, human × Clear all
NCT04551950 2024-03-08

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

EMD Serono

Phase 1 Completed
25 enrolled 14 charts
Gynecologic

Uterine Cervical Neoplasms, Camurati-Engelmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡